177 related articles for article (PubMed ID: 20356977)
1. Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase.
Zeng L; Biernacka KM; Holly JM; Jarrett C; Morrison AA; Morgan A; Winters ZE; Foulstone EJ; Shield JP; Perks CM
Endocr Relat Cancer; 2010 Jun; 17(2):539-51. PubMed ID: 20356977
[TBL] [Abstract][Full Text] [Related]
2. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
3. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
[TBL] [Abstract][Full Text] [Related]
4. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
Menendez JA; Lupu R
Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
Menendez JA; Colomer R; Lupu R
Med Hypotheses; 2005; 64(2):337-41. PubMed ID: 15607568
[TBL] [Abstract][Full Text] [Related]
6. Targeting fatty acid synthase-driven lipid rafts: a novel strategy to overcome trastuzumab resistance in breast cancer cells.
Menendez JA; Vellon L; Lupu R
Med Hypotheses; 2005; 64(5):997-1001. PubMed ID: 15780499
[TBL] [Abstract][Full Text] [Related]
7. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
8. Oleate activates phosphatidylinositol 3-kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite effects.
Hardy S; Langelier Y; Prentki M
Cancer Res; 2000 Nov; 60(22):6353-8. PubMed ID: 11103797
[TBL] [Abstract][Full Text] [Related]
9. Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival.
Chajès V; Cambot M; Moreau K; Lenoir GM; Joulin V
Cancer Res; 2006 May; 66(10):5287-94. PubMed ID: 16707454
[TBL] [Abstract][Full Text] [Related]
10. Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling.
Weng MS; Ho CT; Ho YS; Lin JK
Toxicol Appl Pharmacol; 2007 Jan; 218(2):107-18. PubMed ID: 17182072
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells.
Bandyopadhyay S; Zhan R; Wang Y; Pai SK; Hirota S; Hosobe S; Takano Y; Saito K; Furuta E; Iiizumi M; Mohinta S; Watabe M; Chalfant C; Watabe K
Cancer Res; 2006 Jun; 66(11):5934-40. PubMed ID: 16740734
[TBL] [Abstract][Full Text] [Related]
12. Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.
Menendez JA; Vellon L; Oza BP; Lupu R
J Cell Biochem; 2005 Apr; 94(5):857-63. PubMed ID: 15669079
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid synthase (FAS): a target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells.
Pizer ES; Wood FD; Pasternack GR; Kuhajda FP
Cancer Res; 1996 Feb; 56(4):745-51. PubMed ID: 8631008
[TBL] [Abstract][Full Text] [Related]
14. Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts.
Pizer ES; Thupari J; Han WF; Pinn ML; Chrest FJ; Frehywot GL; Townsend CA; Kuhajda FP
Cancer Res; 2000 Jan; 60(2):213-8. PubMed ID: 10667561
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells.
Pizer ES; Jackisch C; Wood FD; Pasternack GR; Davidson NE; Kuhajda FP
Cancer Res; 1996 Jun; 56(12):2745-7. PubMed ID: 8665507
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75.
Puig T; Vázquez-Martín A; Relat J; Pétriz J; Menéndez JA; Porta R; Casals G; Marrero PF; Haro D; Brunet J; Colomer R
Breast Cancer Res Treat; 2008 Jun; 109(3):471-9. PubMed ID: 17902053
[TBL] [Abstract][Full Text] [Related]
17. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
Pan MH; Lin CC; Lin JK; Chen WJ
J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid synthase-catalyzed de novo fatty acid biosynthesis: from anabolic-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells.
Menendez JA; Lupu R
Arch Immunol Ther Exp (Warsz); 2004; 52(6):414-26. PubMed ID: 15577743
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells.
Zhou W; Han WF; Landree LE; Thupari JN; Pinn ML; Bililign T; Kim EK; Vadlamudi A; Medghalchi SM; El Meskini R; Ronnett GV; Townsend CA; Kuhajda FP
Cancer Res; 2007 Apr; 67(7):2964-71. PubMed ID: 17409402
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity.
Thupari JN; Pinn ML; Kuhajda FP
Biochem Biophys Res Commun; 2001 Jul; 285(2):217-23. PubMed ID: 11444828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
